Effects of tibolone on human breast cancer cells and human vascular coronary cells

Archives of Gynecology and Obstetrics

Volumn 267, Issue 3, 2003, Pages 139-144

  Mueck, A O ^a   Lippert, C ^a   Seeger, H ^a   Wallwiener, D ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Breast cancer cell growth; Tibolone; Vascular markers

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; INTERSTITIAL COLLAGENASE; TIBOLONE; ENDOTHELIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANE DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER RISK; CELL STRAIN MCF 7; CORONARY BLOOD VESSEL; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; POSTMENOPAUSE OSTEOPOROSIS; PROGESTERONE METABOLISM; PROPHYLAXIS; SMOOTH MUSCLE FIBER; TARGET CELL; VASCULAR ENDOTHELIUM; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CYTOLOGY; FEMALE; METABOLISM; PATHOLOGY; VASCULAR SMOOTH MUSCLE;

BREAST NEOPLASMS; CELL DIVISION; CORONARY VESSELS; E-SELECTIN; ENDOTHELINS; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 1; MUSCLE, SMOOTH, VASCULAR; NORPREGNENES; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR CELLS, CULTURED;

EID: 0037839081     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-002-0291-x     Document Type: Article

References (28)

1. Albertazzi P, Di Micco R, Zanardi E (1998) Tibolone: a review. Maturitas 30:295-305
2. Blankenstein MA, Maitimu-Smeel I, Donker GH, Daroszewski J, Milewicz A, Thijssen JH (1992) On the significance of in situ production of oestrogens in human breast cancer tissue. J Steroid Biochem Mol Biol 41:891-896
3. Chetrite GS, Kloosterboer HJ, Pasqualini JR (1997) Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells. Anticancer Res 17:135-140
4. Chetrite GS, Kloosterboer HJ, Philippe JC, Pasqualini JR (1999) Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells. Anticancer Res 19:261-267
5. Chetrite GS, Kloosterboer HJ, Philippe JC, Pasqualini JR (1999) Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines. Anticancer Res 19:269-275
6. Colacurci N, Mele D, De Franciscis P, Costa V, Fortunato N, De Seta L (1998) Effects of tibolone on the breast. Eur J Obstet Gynecol Reprod Biol 80:235-238
7. Drexler H (1997) Endothelial dysfunction: Clinical Implications. Prog Cardiovasc Dis 39:287-324
8. Ginsburg J, Prelevic G, Butler D, Okolo S (1995) Clinical experience with tibolone (Livial) over 8 years. Maturitas 21:71-76
9. Guidozzi F (1999) Estrogen replacement therapy in breast cancer survivors. Int J Gynaecol Obstet 64:59-63
10. Haenggi W, Bersinger NA, Mueller MD, Birkhäuser MH (1999) Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone. Gynecol Endocrinol 13:202-205
11. Kloosterboer HJ, Schoonen WG, Deckers GH, Klijn JG (1994) Effects of progestagens and Org OD14 in in vitro and in vivo tumor models. J Steroid Biochem Mol Biol 49:311-318
12. Levin EL (1995) Endothelins. N Engl J Med 333:356-363
13. Lippert C, Seeger H, Wallwiener D, Mueck AO (2001) Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate-estradiol treatment on the proliferation of MCF-7 cells. Climacteric 3:271-277
14. Magnusson C, Baron JA, Correia N, Bergström R, Adami HO, Persson I (1999) Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 81:339-344
15. Moore RA (1999) Livial: a review of clinical studies. Br J Obstet Gynaecol 106[Suppl 19]:1-21
16. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith SC, Taubert KA, Wenger NK (2001) Hormone replacement therapy and cardiovascular disease. Circulation 104:499-503
17. Mueck AO, Seeger H, Wallwiener D (2001) Medroxyprogesterone acetate vs norethisterone: Effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. Menopause, in press
18. O'Brien M, Montes A, Powles TJ (1996) Hormone replacement therapy as treatment of breast cancer - a phase II study of Org OD14 (tibolone). Br J Cancer 73:1086-1088
19. Ozdemir A, Konus O, Nas T, Erbas G, Cosar S, Isok S (1999) Mammographic and ultrasonographic study of changes in the breast related to HRT. Int J Gynaecol Obstet 67:23-32
20. Pasqualini JR, Ebert C, Chetrite GS (1999) The SEEM: selective estrogen enzyme modulators in breast cancer. Gynecol Endocrinol 13[Suppl]:61-68
21. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J (1998) Plasma concentrations of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88-92
22. Ross R (1999) Atherosclerosis is an inflammatory disease. Am Heart J 138:S419-S420
23. Ross RK, Paganini-Hill A, Wan PC, Pike MC (2000) Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst 92:328-332
24. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R (2000) Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283:485-49
25. Simoncini T, Genazzani AR (2000) Tibolone inhibits leucocyte adhesion molecule expression in human endothelial cells. Mol Cell Endocrinol 162:87-94
26. Valdivia I, Ortega D (2000) Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy. Clin Drug Invest 20:101-107
27. Winkler UH, Altkemper R, Kwee B, Helmond FA, Coelingh-Bennink HJ (2000) Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. Fertil Steril 74:10-19
28. Zandberg P, Peters JLM, Demacker PN, Smit MJ, de Reeder EG, Smit MJ Meuleman DG (2001) Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits. Menopause 8:96-105